Optimization of autologous stem cell transplantation for systemic sclerosis - A single-center longterm experience in 26 patients with severe organ manifestations

Journal of Rheumatology

Volumn 39, Issue 2, 2012, Pages 269-275

  Henes, Joerg C ^a   Schmalzing, Marc ^a   Vogel, Wichard ^a   Riemekasten, Gabriela ^b   Fend, Falko ^a   Kanz, Lothar ^a   Koetter, Ina ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

CD34 selection; Cyclophosphamide; Granulocyte colony stimulating factor; Stem cell transplant; Systemic sclerosis; Treatment

Indexed keywords

ACICLOVIR; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYTOKINE; FLUCONAZOLE; GRANULOCYTE COLONY STIMULATING FACTOR; LEVOFLOXACIN; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RITUXIMAB; STEROID; THIOTEPA; THYMOCYTE ANTIBODY;

ADULT; AGED; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CAUSE OF DEATH; CD34 SELECTION; CHILL; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HEART DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOTENSION; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; LUNG COMPLICATION; LUNG FUNCTION; LUNG INFILTRATE; MALE; MORTALITY; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RELAPSE; RETROSPECTIVE STUDY; SIDE EFFECT; SKIN FUNCTION; STEM CELL MOBILIZATION; SURVIVAL RATE; SYSTEMIC SCLEROSIS; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

ADULT; AGED; ANTIGENS, CD34; ANTILYMPHOCYTE SERUM; CYCLOPHOSPHAMIDE; DISEASE-FREE SURVIVAL; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SCLERODERMA, SYSTEMIC; SEVERITY OF ILLNESS INDEX; STEM CELLS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84856556682     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.110868     Document Type: Article

References (27)

1. Kowal-Bielecka O, Landewé R, Avouac J, Chwiesko S, Miniati I, Czirjak L, et al. EULAR recommendations for the treatment of systemic sclerosis: A report from the EULAR Scleroderma Trials and Research group (EUSTAR). Ann Rheum Dis 2009;68:620-8.
2. Tyndall A, Gratwohl A. Blood and marrow stem cell transplants in auto-immune disease: A consensus report written on behalf of the European League against Rheumatism (EULAR) and the European Group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant 1997;19:643-5. (Pubitemid 27182485)
3. Farge D, Labopin M, Tyndall A, Fassas A, Mancardi GL, van Laar J, et al. Autologous hematopoietic stem cell transplantation for autoimmune diseases: An observational study on 12 years'experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases. Haematologica 2010;95:284-92.
4. Nash RA, McSweeney PA, Crofford LJ, Abidi M, Chen CS, Godwin JD, et al. High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: Long-term follow-up of the US multicenter pilot study. Blood 2007;110:1388-96. (Pubitemid 47281441)
5. Burt RK, Marmont A, Oyama Y, Slavin S, Arnold R, Hiepe F, et al. Randomized controlled trials of autologous hematopoietic stem cell transplantation for autoimmune diseases - The evolution from myeloablative to lymphoablative transplant regimens. Arthritis Rheum 2006;54:3750-60. (Pubitemid 44955875)
6. Sullivan KM, Muraro P, Tyndall A. Hematopoietic cell transplantation for autoimmune disease: Updates from Europe and the United States. Biol Blood Marrow Transplant 2010;16:48-56.
7. Vonk MC, Marjanovic Z, van den Hoogen FH, Zohar S, Schattenberg AV, Fibbe WE, et al. Long-term follow-up results after autologous haematopoietic stem cell transplantation for severe systemic sclerosis. Ann Rheum Dis 2008;67:98-104.
8. Burt RK, Shah SJ, Dill K, Grant T, Gheorghiade M, Schroeder J, et al. Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): An open-label, randomised phase 2 trial. Lancet 2011;378:498-506.
9. van Laar JM, Farge D, Tyndall A. Autologous Stem cell Transplantation International Scleroderma (ASTIS) trial: Hope on the horizon for patients with severe systemic sclerosis. Ann Rheum Dis 2005;64:1515. (Pubitemid 41623870)
10. Tyndall AJ, Bannert B, Vonk M, Airo P, Cozzi F, Carreira PE, et al. Causes and risk factors for death in systemic sclerosis: A study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann Rheum Dis 2010;69:1809-15.
11. Domsic RT, Rodriguez-Reyna T, Lucas M, Fertig N, Medsger TA Jr. Skin thickness progression rate: a predictor of mortality and early internal organ involvement in diffuse scleroderma. Ann Rheum Dis 2010;70:104-9.
12. Medsger TA, Masi AT, Rodnan GP, Benedek TG, Robinson H. Survival with systemic sclerosis (scleroderma). A life-table analysis of clinical and demographic factors in 309 patients. Ann Intern Med 1971;75:369-76.
13. Steen VD, Medsger TA. Changes in causes of death in systemic sclerosis, 1972-2002. Ann Rheum Dis 2007;66:940-4. (Pubitemid 46999798)
14. Domsic RT, Rodriguez-Reyna T, Lucas M, Fertig N, Medsger TA Jr. Skin thickness progression rate: A predictor of mortality and early internal organ involvement in diffuse scleroderma. Ann Rheum Dis 2011;70:104-9.
15. Ioannidis JP, Vlachoyiannopoulos PG, Haidich AB, Medsger TA Jr, Lucas M, Michet CJ, et al. Mortality in systemic sclerosis: An international meta-analysis of individual patient data. Am J Med 2005;118:2-10. (Pubitemid 40082450)
16. Brodsky RA. High-dose cyclophosphamide for aplastic anemia and autoimmunity. Curr Opin Oncol 2002;14:143-6. (Pubitemid 34235045)
17. Komatsuda A, Kawabata Y, Horiuchi T, Motegi M, Ozawa M, Fujishima N, et al. Successful autologous peripheral blood stem cell transplantation using thiotepa in a patient with systemic sclerosis and cardiac involvement. Tohoku J Exp Med 2006;209:61-7.
18. Giorgetti F, Minnucci ML, Santori P, Ercoli L, Rossi M, Del Papa M, et al. Autologous peripheral stem cell transplantation in a patient with diffuse systemic sclerosis: our experience [Italian]. Reumatismo 2004;56:51-6. (Pubitemid 38506536)
19. Czirják L, Kumánovics G, Varjú C, Nagy Z, Pakozdi A, Szekanecz Z, et al. Survival and causes of death in 366 Hungarian patients with systemic sclerosis. Ann Rheum Dis 2008;67:59-63.
20. Scussel-Lonzetti L, Joyal F, Raynauld JP, Roussin A, Rich E, Goulet JR, et al. Predicting mortality in systemic sclerosis: analysis of a cohort of 309 French Canadian patients with emphasis on features at diagnosis as predictive factors for survival. Medicine 2002;81:154-67. (Pubitemid 34218570)
21. Hosing C, Nash R, McSweeney P, Mineishi S, Seibold J, Griffith LM, et al. Acute kidney injury in patients with systemic sclerosis participating in hematopoietic cell transplantation trials in the United States. Biol Blood Marrow Transplant 2011;17:674-81.
22. Tashkin DP, Elashoff R, Clements PJ, Goldin J, Roth MD, Furst DE, et al. Cyclophosphamide versus placebo in scleroderma lung disease. N Engl J Med 2006;354:2655-66.
23. Hoyles RK, Ellis RW, Wellsbury J, Lees B, Newlands P, Goh NS, et al. A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma. Arthritis Rheum 2006;54:3962-70. (Pubitemid 44955900)
24. Wagner MS, Henes JC, Vogel W, Holzer U, Haug M, Kane L, et al. Immune reconstitution and lymphocyte subpopulations after autologous hematopoietic stem cell transplantation for systemic sclerosis. Ann Rheum Dis 2010;69 Suppl 3:256.
25. Saccardi R, Tyndall A, Coghlan G, Denton C, Edan G, Emdin M, et al. Consensus statement concerning cardiotoxicity occurring during haematopoietic stem cell transplantation in the treatment of autoimmune diseases, with special reference to systemic sclerosis and multiple sclerosis. Bone Marrow Transplant 2004;34:877-81. (Pubitemid 39562137)
26. Arimura K, Inoue H, Kukita T, Matsushita K, Akimoto M, Kawamata N, et al. Acute lung injury in a healthy donor during mobilization of peripheral blood stem cells using granulocyte-colony stimulating factor alone. Haematologica 2005;90:ECR 10.
27. Kopp HG, Horger M, Faul C, Hartmann JT, Kanz L, Lang P, et al. Granulocyte colony-stimulating factor induced pulmonary haemorrhage in a healthy stem cell donor. J Clin Oncol 2007;25:3174-5. (Pubitemid 47218068)